The workforce reduction is part of a restructuring designed to improve accountability and accelerate growth and innovation.

The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.

The collaboration will pair biometric data from the Oura ring with data from glucose sensors and insulin pumps.

Siemens Healthineers has reaffirmed its expectation that the negative impact of tariffs will double in its next fiscal year ...

Qiagen has identified Parse Biosciences’ technology as complementary to its sample technology and bioinformatic businesses.

Medtronic reached a critical juncture last month in its quest to build the market for renal denervation, a new device-based ...

CEO Ivan Tornos said multiple factors emerged late in the quarter that caused the shortfall. Zimmer’s shares plunged more ...

In a letter to CMS Administrator Mehmet Oz, diabetes caucus leaders raised concerns that the agency’s proposals will reduce ...

National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained ...

More than 30 organizations, including AdvaMed and the American Clinical Laboratory Association, are pushing for a permanent ...

A software defect could cause the app to terminate, resulting in missed alerts or alarms. Dexcom required users to update the ...

Integrating a controlled-release iodine layer into hip implants could reduce the rate of potentially fatal infections.